Federal health regulators have given the green light to a new psychiatric medication developed by Vanda Pharmaceuticals, marking another treatment option for patients with severe mental health disorders.
The pharmaceutical company announced Friday that the Food and Drug Administration has cleared their drug for treating two serious psychiatric conditions, though specific details about the conditions were not disclosed in the initial announcement.
The approval represents a significant milestone for Vanda Pharmaceuticals as they bring their mental health treatment to market for patients who may benefit from this new therapeutic option.
